Skip to main content
Yoshua Esquenazi Levy, MD, Neurosurgery, Houston, TX

YoshuaEsquenazi LevyMD

Neurosurgery Houston, TX

Director of Neurosurgical Oncology, The University of Texas Health Science Center at Houston, McGovern Medical School Vivian L. Smith Department of Neurosurgery

Dr. Esquenazi Levy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Esquenazi Levy's full profile

Already have an account?

  • Office

    6400 Fannin St
    Ste 2800
    Houston, TX 77030
    Phone+1 713-486-8000
    Fax+1 713-486-8088

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Neurological Surgery, 2009 - 2015
  • Mayo Clinic College of Medicine and Science
    Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2008 - 2009
  • Universidad Anahuac School of Medicine
    Universidad Anahuac School of MedicineClass of 2007

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2016 - 2025
  • NY State Medical License
    NY State Medical License 2015 - 2017
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Houstonia Top Doctors Neurosurgery 2018
  • AOA-Spine 2015
  • Resident Award Alpha Omega Alpha Honor Medical Society Delta Chapter, 2014
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma  
    Hovinga KE, McCrea HJ, Brennan C, Huse J, Zheng J, Esquenazi Y, Panageas KS, Tabar V, J Neurooncol, 1/24/2019
  • Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma  
    Morris SA, Zhu P, Rao M, Zhu JJ, Hsu S, Ballester LY, Day AL, Tandon N, Kim DH, Shephard S, Blanco AI, Esquenazi Y, World Neurosurgery, 1/1/2019
  • Telomerase Reverse Transcriptase (TERT) alterations in Human Cancers; Diagnosis, Prognosis and Therapeutic Implications  
    Esquenazi Y, Ballester LY, Cancer Cytopathology, 1/1/2019
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Differentiating Abscess from Necrosis by ADC value measurement.
    Kamali A, Doyle N, Rabiei P, Lugo A, Zhu JJ, Esquenazi Y, Patel R, Riascos R, ASNR 57th Annual Meeting, Boston, MA, 1/1/2019
  • Access to clinical trials, multidisciplinary environment, and health care providers by facility type and outcomes of patients with newly diagnosed glioblastoma using t...
    Zhu P, Du X, Esquenazi Y, Zhu J, ASCO, Chicago, IL, 1/1/2019
  • Impact of Travel Distance to Care Facility on Survival in Patients with Glioblastoma: A Retrospective Study Using the National Cancer Database.
    Zhu P, Du X, Esquenazi Y, Zhu J, American Academy of Neurology 71st Annual Meeting, Philadelphia, PA, 1/1/2019
  • Join now to see all

Lectures

  • The 2016 World Health Organization Classification of Tumors of the Central Nervous System 
    Guadalajara, Mexico, 2018; Hotel RIU, Guadalajara, Mexico, 2019 - 1/26/2019
  • Neurosurgical Emergencies � Imaging findings and management 
    Hotel RIU, Guadalajara, Mexico - 1/26/2019
  • Feasibility of a Liquid Biopsy assay in CNS tumors. 
    Memorial Sloan Kettering Cancer Center, Rockefeller Research Institute, New York, NY - 1/25/2019
  • Join now to see all

Other

  • Hydrocephalus (Water in the brain). (Media Appearance) 
    Esquenazi Y, Univision: afternoon news network, Channel 45
    Houston, TX - 1/1/2017
  • Laser treatment for brain tumors. (Media Appearance) 
    Esquenazi Y, Univision: Special Health report, Channel 45
    1/1/2017
  • Primary and secondary brain tumors. (Media Appearance) 
    Esquenazi Y, Univision: morning news network, Channel 45
    Houston, TX - 1/1/2016

Professional Memberships